CryoEMPEM Antibody Sequencing from Polyclonal Serum
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional methods for antibody isolation and characterization are time-consuming, costly, and inefficient, particularly when dealing with large numbers of monoclonal antibodies, as they require extensive B-cell sorting and high-resolution structural characterization for each unique sample, limiting the ability to efficiently analyze and identify antibodies binding to various epitopes.
Innovation Solution
The method involves cryogenic electron microscopy-based polyclonal epitope mapping (cryoEMPEM) to determine structural information of antigen-antibody complexes, coupled with next-generation sequencing (NGS) to identify and predict monoclonal antibody sequences, allowing for the synthesis and verification of antibodies that interact with antigens, thereby bypassing the need for single B-cell sorting and reducing the complexity of high-resolution characterization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional B-cell sorting and individual antibody characterization methods are used, then high-resolution structural information and epitope specificity can be obtained, but the process becomes extremely time-consuming and resource-intensive when dealing with large numbers of monoclonal antibodies
Solution Approach 1:
The patent combines cryoEM imaging of polyclonal serum samples with next-generation sequencing (NGS) data to simultaneously obtain structural information and antibody sequences. Instead of processing individual monoclonal antibodies separately, the method analyzes the entire polyclonal mixture in one cryoEM experiment, merging structural biology with sequencing technologies to resolve the contradiction between precision and time consumption.
Solution Approach 2:
The cryoEM-based polyclonal epitope mapping (cryoEMPEM) approach serves multiple functions: it provides high-resolution structural characterization of antigen-antibody complexes, identifies epitope specificities, and when combined with NGS, determines antibody sequences. This multi-functional method eliminates the need for separate experiments for each antibody, dramatically reducing analysis time while maintaining precision.
2Reliability
If extensive B-cell sorting and individual antibody analysis are performed, then comprehensive epitope specificity and affinity data can be obtained, but reagent requirements and operational complexity increase significantly
Solution Approach 1:
The patent uses cryoEM to capture three-dimensional structural copies of antigen-antibody complexes directly from polyclonal serum, preserving epitope specificity information without requiring physical separation of individual antibodies. The high-resolution density maps serve as structural copies that can be analyzed computationally to determine binding characteristics, simplifying the operational process while maintaining reliability.
3Measurement precision
If high-resolution structural characterization is performed on each unique antibody sample, then detailed binding and functional information can be obtained, but the device complexity and resource requirements increase
Solution Approach 1:
The patent merges cryoEM structural biology with next-generation sequencing technologies to create an integrated workflow. A single cryoEM dataset of polyclonal serum complexed with antigen provides structural information for multiple antibodies simultaneously, and the corresponding NGS data provides sequence information, eliminating the need for separate high-resolution structural experiments on each antibody.
Solution Approach 2:
The polyclonal serum sample itself serves as the source of multiple monoclonal antibodies, and the cryoEMPEM method automatically identifies and characterizes the dominant antibody populations within the mixture. The method leverages the natural composition of the polyclonal sample, allowing direct identification of monoclonal antibody sequences and structures without requiring extensive manual sorting or purification steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables efficient identification and characterization of monoclonal antibodies, reducing the time and cost of analysis, allowing for the rapid identification of clonal family members and their synthesis, which can be used for disease treatment, vaccine design, and immunotherapeutic development.
Implementation Method 1
Sequencing polyclonal antibodies directly from single particle cryoem data
Data Source
AI summary
Provided herein are methods for discovery of epitope specific monoclonal antibodies to pathogens directly from immune sera for immunotherapeutic use. Further provided herein are methods to determine molecular structure of antibodies targeting an antigen from convalescent or vaccinated individuals for the purpose of rational vaccine design.